skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability

Journal Article · · Journal of Virology
DOI:https://doi.org/10.1128/JVI.01715-16· OSTI ID:1351400
 [1];  [2];  [1];  [2];  [2];  [2];  [3];  [4]
  1. Icahn School of Medicine at Mount Sinai, New York, NY (United States)
  2. Washington Univ. School of Medicine in St. Louis, St. Louis, MO (United States)
  3. Icahn School of Medicine at Mount Sinai, New York, NY (United States); Georgia State Univ., Atlanta, GA (United States)
  4. Wake Forest Univ., Winston-Salem, NC (United States)

Zaire ebolavirus (EBOV), Bundibugyo ebolavirus (BDBV), and Reston ebolavirus (RESTV) belong to the same genus but exhibit different virulence properties. VP24 protein, a structural protein present in all family members, blocks interferon (IFN) signaling and likely contributes to virulence. Inhibition of IFN signaling by EBOV VP24 (eVP24) involves its interaction with the NPI-1 subfamily of karyopherin alpha (KPNA) nuclear transporters. Here, we evaluated eVP24, BDBV VP24 (bVP24), and RESTV VP24 (rVP24) interactions with three NPI-1 subfamily KPNAs (KPNA1, KPNA5, and KPNA6). Using purified proteins, we demonstrated that each VP24 binds to each of the three NPI-1 KPNAs. bVP24, however, exhibited approximately 10-fold-lower KPNA binding affinity than either eVP24 or rVP24. Cell-based assays also indicate that bVP24 exhibits decreased KPNA interaction, decreased suppression of IFN induced gene expression, and a decreased half-life in transfected cells compared to eVP24 or rVP24. Amino acid sequence alignments between bVP24 and eVP24 also identified residues within and surrounding the previously defined eVP24-KPNA5 binding interface that decrease eVP24-KPNA affinity or bVP24-KPNA affinity. VP24 mutations that lead to reduced KPNA binding affinity also decrease IFN inhibition and shorten VP24 half-lives. Here, these data identify novel functional differences in VP24-KPNA interaction and reveal a novel impact of the VP24-KPNA interaction on VP24 stability. The interaction of Ebola virus (EBOV) VP24 protein with host karyopherin alpha (KPNA) proteins blocks type I interferon (IFN) signaling, which is a central component of the host innate immune response to viral infection. Here, we quantitatively compared the interactions of VP24 proteins from EBOV and two members of the Ebolavirus genus, Bundibugyo virus (BDBV) and Reston virus (RESTV). The data reveal lower binding affinity of the BDBV VP24 (bVP24) for KPNAs and demonstrate that the interaction with KPNA modulates inhibition of IFN signaling and VP24 stability. The effect of KPNA interaction on VP24 stability is a novel functional consequence of this virus-host interaction, and the differences identified between viral species may contribute to differences in pathogenesis.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
National Institutes of Health (NIH)
Grant/Contract Number:
AI109945; AI120943; AI007647
OSTI ID:
1351400
Journal Information:
Journal of Virology, Vol. 91, Issue 4; ISSN 0022-538X
Publisher:
American Society for MicrobiologyCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 11 works
Citation information provided by
Web of Science

References (28)

Taxonomy of the order Mononegavirales: update 2016 journal May 2016
West Africa 2013: Re-examining Ebola journal June 2016
Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda journal November 2008
Single Immunization With a Monovalent Vesicular Stomatitis Virus–Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirus journal November 2011
Epidemiology of Ebola (Subtype Reston) Virus in the Philippines, 1996 journal February 1999
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus journal October 2015
VP24 of Marburg Virus Influences Formation of Infectious Particles journal October 2005
Infection of Naive Target Cells with Virus-Like Particles: Implications for the Function of Ebola Virus VP24 journal June 2006
Knockdown of Ebola Virus VP24 Impairs Viral Nucleocapsid Assembly and Prevents Virus Replication journal November 2011
Regions in Ebola Virus VP24 That Are Important for Nucleocapsid Formation journal November 2007
Ebola Virus (EBOV) VP24 Inhibits Transcription and Replication of the EBOV Genome journal November 2007
Molecular Determinants of Ebola Virus Virulence in Mice journal January 2006
Molecular Characterization of Guinea Pig-Adapted Variants of Ebola Virus journal November 2000
VP24 Is a Molecular Determinant of Ebola Virus Virulence in Guinea Pigs journal November 2011
Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells journal November 2015
Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1 journal August 2014
Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus journal January 2010
Predicting the rate enhancement of protein complex formation from the electrostatic energy of interaction 1 1Edited by B. Honig journal March 1999
Importin α Nuclear Localization Signal Binding Sites for STAT1, STAT2, and Influenza A Virus Nucleoprotein journal May 2003
Regulation of Stat3 nuclear import by importin α5 and importin α7 via two different functional sequence elements journal August 2006
Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1 journal December 1997
Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses journal February 2015
Structural basis for Marburg virus VP35-mediated immune evasion mechanisms journal November 2012
Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model journal June 2015
Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection journal October 2012
Studies of Reservoir Hosts for Marburg Virus journal December 2007
The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold journal February 2012
The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway journal March 2014

Cited By (7)

Filovirus Strategies to Escape Antiviral Responses book January 2017
Treatment-focused Ebola trials, supportive care and future of filovirus care journal December 2017
Is the Bombali virus pathogenic in humans? journal April 2019
Regulation of the Ebola Virus VP24 Protein by SUMO journal October 2019
Importin α1 is required for nuclear import of herpes simplex virus proteins and capsid assembly in fibroblasts and neurons journal January 2018
Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism journal December 2017
Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling journal February 2018

Similar Records

Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells
Journal Article · Sun Nov 15 00:00:00 EST 2015 · Virology · OSTI ID:1351400

Structural basis for Marburg virus VP35-mediated immune evasion mechanisms
Journal Article · Mon Jul 22 00:00:00 EDT 2013 · Proceedings of the National Academy of Sciences of the United States of America · OSTI ID:1351400

Dimerization Controls Marburg Virus VP24-dependent Modulation of Host Antioxidative Stress Responses
Journal Article · Thu Aug 04 00:00:00 EDT 2016 · Journal of Molecular Biology · OSTI ID:1351400